3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
2
Rhabdoid Tumor
1
Papillary renal cell carcinoma, sporadic
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hereditary leiomyomatosis and renal cell cancer
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma
1
Breast Neoplasms
1
Interventions
fludarabine
17
Cyclophosphamide
15
Specimen Handling
14
Biopsy
12
fludarabine phosphate
11
Melphalan
10
Cytarabine
10
Busulfan
10
Mycophenolic Acid
9
venetoclax
8
Whole-Body Irradiation
8
Tacrolimus
8
decitabine and cedazuridine drug combination
7
Granulocyte Colony-Stimulating Factor
7
Injections
6
Cyclosporine
6
Azacitidine
6
Stem Cell Transplantation
5
Sirolimus
5
Filgrastim
5
X-Rays
4
Thiotepa
4
Peripheral Blood Stem Cell Transplantation
4
Idarubicin
4
CPX-351
4
ruxolitinib
3
Magnetic Resonance Spectroscopy
3
Hematopoietic Stem Cell Transplantation
3
Decitabine
3
treosulfan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Erlotinib Hydrochloride
×
30 days
×
Clear all
No trials found.